Hypercalcemia Is of Uncertain Significance in Patients With Advanced Adenocarcinoma of the Prostate.
Federal practitioner : for the health care professionals of the VA, DoD, and PHS(2020)
摘要
Hypercalcemia in the setting of prostate cancer is rare with an uncertain pathophysiology and more research is needed into the role of parathyroid hormone-related peptide as a growth factor and possibly target-directed monoclonal antibody therapies.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要